<p>Safety and Efficacy of Lenvatinib Treatment in Child–Pugh A and B Patients with Unresectable Hepatocellular Carcinoma in Clinical Practice: A Multicenter Analysis</p>
Katsuaki Ogushi(Yokohama City University Medical Center), Shin Maeda(University of Tokyo Hospital), Y. Sano(Shiga University of Medical Science), Hisashi Hidaka(Kitasato University), Tomoaki Fujikawa(Fujisawa City Hospital), Makoto Chuma(Yokohama City University Medical Center), Nobuhiro Hattori(St. Marianna University School of Medicine), Kazushi Numata(Yokohama City University Medical Center), Yusuke Saigusa(Yokohama City University), Satoshi Kobayashi(Kanagawa Cancer Center), Makoto Kako(Shonan Kamakura General Hospital), Takahide Nakazawa(Kitasato University Hospital), Makoto Ueno(Kanagawa Prefectural Hospital Organization), Shuichiro Iwasaki(Kitasato University), Kotaro Matsunaga(St. Marianna University School of Medicine), Naohisa Wada(Kitasato University), Kota Tsuruya(Tokai University), Yosuke Kunishi, Kuniyuki Kawano(Kanagawa Prefectural Hospital Organization), Tatehiro Kagawa(Tokai University), Shunji Hirose(Tokai University), Haruki Uojima(National Center for Global Health and Medicine), Tsunamasa Watanabe(St. Marianna University School of Medicine), Katsuaki Tanaka(Yokohama City University Medical Center), Manabu Morimoto(Kanagawa Prefectural Hospital Organization), Kuniyasu Irie(Yokohama City University Hospital), Masako Shomura(Tokai University), Shogo Iwabuchi(Jikei University School of Medicine), Taito Fukushima(Kanagawa Prefectural Hospital Organization)
Cited by 55
Related Papers
Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
|The Lancet Oncology|2018|2.5k
Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells.
|Journal of Biological Chemistry|1990|1.5k
KN-62, 1-[N,O-bis(5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-phenylpiperazi ne, a specific inhibitor of Ca2+/calmodulin-dependent protein kinase II.
|Journal of Biological Chemistry|1990|625
N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide, a calmodulin antagonist, inhibits cell proliferation.
|Proceedings of the National Academy of Sciences|1981|586